-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US4622221004-
Ionis PharmaceuticalsBörse Börse FrankfurtEURSymbol ISI
-
Ionis PharmaceuticalsBörse Börse BerlinEURSymbol ISI
-
Ionis PharmaceuticalsBörse Börse MünchenEURSymbol ISI
-
IONIS PHARMACEUTICALS INCBörse Quotrix System der Börse DüsseldorfEURSymbol ISI
-
IONIS PHARMACEUTICALS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol ISI
-
IONIS PHARMACEUTICALS INCBörse Börse StuttgartEURSymbol ISI
-
IONIS PHARMACEUTICALS INCBörse Gettex System der Börse MünchenEURSymbol ISI
-
IONIS PHARMACEUTICALS INCBörse Börse DüsseldorfEURSymbol ISI
-
Ionis PharmaceuticalsBörse NasdaqISIN US4622221004 WKN: A2ACMZUSDSymbol IONS
-
ISIN US4622221004 WKN: A2ACMZUSDSymbol IONS
-
MXN
-
USD
-
ISIN US4622221004
WKN A2ACMZ
Symbol IONS
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Ionis Pharmaceuticals, Inc
Marktkapitalisierung
6.339.973.376 (+- 33%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
8.415.946.752 oder 4.264.000.000
Mitarbeiter
807 (+- 1%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
817 oder 796 Mitarbeiter
KGV
116.2
EBITDA 128.645.000
PEGRatio 25.7033
Buchwert 9.894
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 37,24 USD +1,52%
Portrait der Ionis Pharmaceuticals Aktie
Das Unternehmen Ionis Pharmaceuticals, Inc aus USA beschäftigt 807 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Das Unternehmen Ionis Pharmaceuticals, Inc ist in ungefähr 11 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Ionis Pharmaceuticals mit 1,14% im ETF.
Entdecke die 6 ETFs in denen Ionis Pharmaceuticals, Inc am höchsten gewichtet ist Insgesamt in 11 ETFs enthalten
Dir gefallen die Informationen zu Ionis Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Ionis Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Ionis Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Ionis Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
40 News & Informationen zur Ionis Pharmaceuticals Aktie
Diversifizierte Biotechnologie mit Dividende in einem Wert
Warum die Aktie von BB Biotech für mich die perfekte Investition im Biotechnologie-Sektor ist: Mehrere Titel zugleich, verteilte Risiken und eine hohe Dividende.
Bvf Inc Buys GH Research PLC, argenx SE, Syndax Pharmaceuticals Inc, Sells , Ionis Pharmaceuticals Inc, IDEAYA Biosciences Inc
GuruFocus Article or News written by insider and the topic is about:
PDT Partners, LLC Buys Stellantis NV, Asana Inc, Charles River Laboratories International Inc, Sells Ferrari NV, Tesla Inc, The Toro Co
GuruFocus Article or News written by insider and the topic is about:
Eversept Partners, LLC Buys Bristol-Myers Squibb Company, Community Health Systems Inc, Organon, Sells , TG Therapeutics Inc, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
Sabby Management, Llc Buys Cocrystal Pharma Inc, Enochian BioSciences Inc, Aterian Inc, Sells Second Sight Medical Products Inc, Asensus Surgical Inc, Penn National Gaming Inc
GuruFocus Article or News written by insider and the topic is about:
AtonRa Partners Buys Marvell Technology Inc, SolarEdge Technologies Inc, Veeva Systems Inc, Sells Guardant Health Inc, Vertex Pharmaceuticals Inc, Illumina Inc
GuruFocus Article or News written by insider and the topic is about:
Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia on Q2 2021 Results – Earnings Call Transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2021 Earnings Conference Call August 04, 2021, 11:30 ET Company Participants David Nakasone – IR Brett Monia – Founder, CEO & Director…
Ionis Pharmaceuticals, inc (IONS) Q2 2021 Earnings Call Transcript
IONS earnings call for the period ending June 30, 2021.
Ionis Completes Enrollment In Pivotal NEURO-TTRansform Study Of Eplontersen
CARLSBAD, Calif., July 29, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. IONS, the leader in RNA-targeted therapies, today announced it has completed
Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen
/PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced it has completed enrollment of…
Biogen : Phase 1b Study On Alzheimer's Disease Meets Primary Objective Of Safety & Tolerability
(RTTNews) – A Phase 1b placebo-controlled, multiple ascending dose clinical study data showed that BIIB080/IONIS-MAPTRx met its primary objective …
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
CAMBRIDGE, Mass. and CARLSBAD, Calif., July 26, 2021 /PRNewswire/ — Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) ann…
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
/PRNewswire/ — Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that topline data from a Phase 1b placebo-controlled,…
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Cathie Wood’s ARK Invest Buys Over 800,000 Shares of Quantum-Si – 24/7 Wall St.
One of Cathie Wood's Ark Invest funds bought over 800,000 shares of Quantum-Si on July 22.
5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021
These biotech stocks could have great long-term potential.
Cathie Wood’s ARK Invest Buys for 7
Here's a look at the ARK Invest buys for July 22, 2021.
Cathie Wood’s ARK Invest Buys Over 600,000 Shares of DraftKings – 24
A couple of Cathie Wood's ARK Invest funds bought over 600,000 shares of DraftKings on July 21.
Ionis to hold second quarter 2021 financial results webcast
/PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, August 4th at 11:30 a.m. Eastern Time…
Hedge Funds Are Selling Ionis Pharmaceuticals, Inc. (IONS)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed…
Hedge Funds Are Selling Dada Nexus Limited (DADA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first…
Worldwide RNA Therapeutics Industry – Featuring BioNTech, Moderna Therapeutics And CureVac Among Others
DUBLIN, July 15, 2021 /PRNewswire/ — The
Worldwide RNA Therapeutics Industry – Featuring BioNTech, Moderna Therapeutics and CureVac Among Others
/PRNewswire/ — The
Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director
Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director Oxford, UK – 15 July, 2021: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or…
Sonoco Products Company (SON): Hedge Funds Are Snapping Up
Is Sonoco Products Company (NYSE:SON) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question…
3 Cathie Wood Stocks You Can Buy for Less Than $50
You can get a lot of bang for the buck with these picks.
2 Reasons to Buy Intellia — and 1 Big Reason Why I Won't
After the clinical-stage biotech publicized promising data for its gene-editing treatment of a rare and fatal disease, its stock skyrocketed.
Sarepta, Vertex, Neurocrine: There’s Deep Value In These Beaten Down Healthcare Stocks
Our theme of Out Of Favor Health Care Stocks includes healthcare and pharma names that are seeing a disconnect between their financial performance and stock price returns. Specifically, the theme filters for healthcare companies that have grown revenue by at least 50% over the last three years…
Five Star Stocks on Deep Discount
Still deals to be had in the bull run.
Cathie Wood’s ARK Invest Buys for 6
Here's a look at the ARK Invest buys for June 29, 2021.
Cathie Wood’s ARK Invest Buys Over 460,000 Shares of Quantum-Si – 24/7 Wall St.
One of Cathie Wood's Ark Invest funds bought over 460,000 shares of Quantum-Si on June 28.
Intellia Shares Soar on Positive Test Results
GuruFocus Article or News written by Barry Cohen and the topic is about: Merck, Sanofi, Gilead and others stand to benefit from clinical trials
Cathie Wood’s ARK Invest Buys Over 220,000 Shares of Trimble – 24
One of Cathie Wood's Ark Invest funds bought over 220,000 shares of Trimble on June 26.
Cathie Wood’s ARK Invest Buys and Sells for 6
Here's a look at the ARK Invest trades for June 25, 2021.
Ionis Pharmaceuticals Stock Looks Attractive At $37
We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is undervalued at current levels of under $37. IONS stock is down 11% from the levels of around $42 it was at on March 23, 2020…
Ionis Pharmaceuticals Inc (IONS): Price Now Near $40.46; Daily Chart Shows Downtrend on 20 Day Basis
3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
They're all about lowering your risk.
Ionis Pharmaceuticals: Investor Day Showcases Deep Pipeline, But Lofty Expectations Are A Hurdle (NASDAQ:IONS)
Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA (nusinersen) in Patients Treated With Zolgensma (onasemnogene abeparvovec)
The global Phase 4 RESPOND study will evaluate the efficacy and safety of SPINRAZA in patients with a suboptimal clinical response to ZolgensmaClinical and real-world experience have reported… | January 8, 2021
BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021?
Our theme of Out Of Favor Health Care Stocks includes health care names that have witnessed strong growth and improving fundamentals over the last few years but have still underperformed over 2020, partly due to Covid-19 related disruptions of the health care industry…